We are live on ! Find out more
BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Delisted

BMY.RT was delisted on the 31st of December, 2020.

Back to rankings

12 hedge funds and large institutions have $5.25M invested in Bristol-Myers Squibb Company Contingent Value Rights in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 529 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

98% less funds holding

Funds holding: 546 → 12 (-534)

98% less capital invested

Capital invested by funds: $338M → $5.25M (-$333M)

100% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 529

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

Holders
12
Holders Change
-534
Holders Change %
-97.8%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
529
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
JCI
Jet Capital Investors
New York
+$2.15M
2
TNB
Thomasville National Bank
Georgia
+$146K

Top Sellers

1
PCM
Pentwater Capital Management
Florida
-$47.7M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$20.6M
3
ACM
Abrams Capital Management
Massachusetts
-$17.1M
4
FCM
Farallon Capital Management
California
-$14.8M
5
BFS
Bard Financial Services
Connecticut
-$13.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
Stifel Financial
101
Stifel Financial
Missouri
– -$283K -411,078 Closed
DAM
102
DLD Asset Management
New York
– -$276K -400,000 Closed
O
103
OrbiMed
New York
– -$276K -400,000 Closed
BHMP
104
Bardin Hill Management Partners
New York
– -$268K -388,022 Closed
Franklin Resources
105
Franklin Resources
California
– -$267K -386,415 Closed
Balyasny Asset Management
106
Balyasny Asset Management
Illinois
– -$262K -379,000 Closed
GLAM
107
Gardner Lewis Asset Management
Pennsylvania
– -$255K -370,123 Closed
MGIM
108
M&G Investment Management
United Kingdom
– -$356 -356,454 Closed
CAC
109
Cowen and Company
New York
– -$242K -350,000 Closed
Korea Investment Corp
110
Korea Investment Corp
South Korea
– -$235K -340,870 Closed
TCA
111
Transcend Capital Advisors
New Jersey
– -$209K -302,773 Closed
Wells Fargo
112
Wells Fargo
California
– -$207K -300,677 Closed
AIMCA
113
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$207K -300,000 Closed
OFCM
114
One Fin Capital Management
California
– -$207K -300,000 Closed
SM
115
Sabby Management
Florida
– -$207K -300,000 Closed
PDM
116
Penn Davis McFarland
Texas
– -$204K -295,449 Closed
PCM
117
Prelude Capital Management
New York
– -$201K -291,332 Closed
Fifth Third Bancorp
118
Fifth Third Bancorp
Ohio
– -$196K -283,453 Closed
Neuberger Berman Group
119
Neuberger Berman Group
New York
– -$177K -256,428 Closed
JGC
120
J. Goldman & Co
New York
– -$177K -256,245 Closed
SAM
121
Storebrand Asset Management
Norway
– -$175K -253,369 Closed
Walleye Trading
122
Walleye Trading
New York
– -$170K -245,900 Closed
KBC Group
123
KBC Group
Belgium
– -$897K -236,376 Closed
California Public Employees Retirement System
124
California Public Employees Retirement System
California
– -$161K -233,900 Closed
TD Asset Management
125
TD Asset Management
Ontario, Canada
– -$156K -225,742 Closed
3 4
5
6 7

BMY.RT Hedge Fund Activity: Q1 2021 in Review

12 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) for Q1 2021, worth a combined $5.25M — down 98% from $338M a quarter earlier.

Sellers outnumbered buyers: 529 funds closed out of BMY.RT and 2 opened new positions — a net loss of 527 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Jet Capital Investors, adding an estimated $2.15M. The largest seller was Pentwater Capital Management, exiting entirely with an estimated $47.7M sold.

  • 12 institutional investors held Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) as of Q1 2021, down from 546 in Q4 2020.
  • Funds reported $5.25M of Bristol-Myers Squibb Company Contingent Value Rights stock for Q1 2021, down 98% quarter-over-quarter.
  • 2 funds opened new Bristol-Myers Squibb Company Contingent Value Rights positions in Q1 2021 and 529 closed out, a net change of -527 holders.
  • The largest Bristol-Myers Squibb Company Contingent Value Rights buyer in Q1 2021 was Jet Capital Investors, an estimated $2.15M added.
  • The largest Bristol-Myers Squibb Company Contingent Value Rights seller in Q1 2021 was Pentwater Capital Management, an estimated $47.7M sold.

Based on aggregated 13F filings for Q1 2021.